Graphite Bio
NEWS
Graphite Bio merged with LENZ Therapeutics in March 2024.
As BioSpace proudly introduces our 2022 Hotbed Maps, let’s explore the industry’s most thriving territories, research leading employers and search for relevant jobs on BioSpace.
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
Multiple pharma company stocks make their first appearance on the Nasdaq this morning to advance the next-generation therapeutics. BioSpace takes a look at some of these IPOs.
The last few weeks have seen a flurry of filings for initial public offerings by biotech companies. Here’s a look.
Life sciences money is seemingly growing on trees this year. Here’s who picked a good harvest this week.
Several biotech companies have announced closings of million-dollar financing rounds Monday, with Cambridge, Mass.-based cell and gene therapy company ElevateBio leading the pack. ElevateBio announced it raised $525 million in a Series C financing round, which the company says should help expand its drug programs as well as manufacturing capacity and current and future partnerships.
The company was backed by Versant Ventures, which supported the launch of CRISPR Therapeutics.
IN THE PRESS